Gynecology and Reproductive Endocrinology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Opinion Article - Gynecology and Reproductive Endocrinology (2023) Volume 7, Issue 5

Pelvic masses and uterine cancer: Empowering women through education

Annamaria Shulman *

Department of Obstetrics and Gynecology, Central South University, Changsha, People’s Republic of China

*Corresponding Author:
Annamaria Shulman
Department of Obstetrics and Gynecology
Central South University
Changsha, People’s Republic of China.

Received: 28-Aug-2023, Manuscript No. AAGGS-23-112720; Editor assigned: 31-Aug-2023, PreQC No. AAGGS-23-112720 (PQ); Reviewed:18-Sep-2023, QC No. AAGGS-23-112720; Revised:20-Sep-2023, Manuscript No. AAGGS-23-112720 (R); Published: 26-Sep-2023, DOI:10.35841/2591-7994-7.5.168

Citation: Shulman A. Pelvic masses and uterine cancer: Empowering women through education. Gynecol Reprod Endocrinol. 2023;7(5):168

Visit for more related articles at Gynecology and Reproductive Endocrinology


Uterine cancer, also known as endometrial cancer, is the most common cancer of the female reproductive system in the United States. While it primarily affects postmenopausal women, it can occur at any age. One of the challenges in managing uterine cancer is its subtle onset, often accompanied by vague symptoms. Pelvic masses, which can be an early sign of uterine cancer, should not be ignored. This article aims to emphasize the importance of empowering women through education about pelvic masses and uterine cancer, shedding light on the significance of early detection and treatment [1].

Pelvic masses are abnormal growths that develop in the pelvic area. They can be cysts, fibroids, or tumors. While not all pelvic masses indicate cancer, they should be taken seriously, as they could potentially be related to uterine cancer. Common symptoms associated with pelvic masses include pelvic pain, bloating, changes in urinary or bowel habits, and abnormal bleeding. It is crucial for women to understand the potential connection between pelvic masses and uterine cancer. While not all pelvic masses are cancerous, some may be indicative of malignancy, particularly if they exhibit certain characteristics. These characteristics may include rapid growth, irregular shape, and proximity to the uterus. However, only a medical evaluation can determine the nature of a pelvic mass, so early detection and consultation with a healthcare professional are essential. Education begins with awareness of the risk factors associated with uterine cancer. Age, obesity, hormone imbalances, and a family history of uterine or colorectal cancer are among the factors that can increase a woman's risk. By understanding these risk factors, women can better assess their own susceptibility and take proactive steps towards prevention [2].

Women should be educated about the common symptoms of uterine cancer, which may include abnormal vaginal bleeding (especially postmenopausal bleeding), pelvic pain, and changes in urinary or bowel habits. These symptoms may also be attributed to other benign conditions, but their persistence should prompt further investigation. Encouraging women to prioritize regular health check-ups and screenings is crucial. Routine gynaecological exams can help detect pelvic masses and other potential issues at an early stage when they are more manageable. Women should not hesitate to discuss any concerning symptoms with their healthcare providers [3,4].

Educating women about the various diagnostic tests available is essential for informed decision-making. Transvaginal ultrasound, endometrial biopsy, and pelvic imaging are among the tools that healthcare professionals use to evaluate pelvic masses and diagnose uterine cancer. Being aware of these tests and their purposes can help women feel more in control of their healthcare journey. Empowering women to seek second opinions if they have concerns about their diagnosis or treatment options is essential. Second opinions can provide additional perspectives and ensure that patients are making informed decisions about their care. Creating and maintaining support networks can significantly benefit women facing uterine cancer. Support groups, online forums, and healthcare professionals can provide valuable information and emotional support throughout the treatment process [5].


Empowering women through education about pelvic masses and uterine cancer is a crucial step in early detection and successful treatment. While uterine cancer can be a frightening diagnosis, knowledge and awareness can help women take control of their health and make informed decisions about their care. Recognizing the risk factors, understanding symptoms, and staying proactive with regular check-ups are all part of the educational journey that can ultimately save lives. It is our collective responsibility to ensure that women have access to the information and resources they need to advocate for their own health and well-being. By doing so, we can empower women to take charge of their health and reduce the impact of uterine cancer on their lives.


  1. Bergen TA, Fokin VA, Trufanov GE. Systematization of the magnetic resonance protocol for primarily identified pelvic malignant masses in women. J Med Imaging Radiat Oncol. 2020(4):41-8.
  2. Indexed at, Google Scholar, Cross Ref

  3. Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common and uncommon large pelvic masses. Radiographics. 2003;23(2):403-24.
  4. Indexed at, Google Scholar, Cross Ref

  5. N Gbesso RD, N’Goan AM, Coulibaly A, et al. Uterovaginal and pelvic masses in black African women: the contribution of echographic examination. 1996;6(3):145-50.
  6. Indexed at, Google Scholar

  7. Ezem BU, Osuagwu CC, Onyiaorah IV. Krukenberg tumour simulating uterine fibroids and pelvic inflammatory disease. Niger J Clin Pract. 2010;13(3).
  8. Indexed at, Google Scholar, Cross Ref

  9. Srinivas GN, Chalageri AB, Gupta A, et al. Bilateral ovarian actinomycosis masquerading as ovarian malignancy; without any history of intra-uterine contraceptive device. Med J Dr D.Y Patil Vidyapeeth. 2013;6(4):468-71.
  10. Indexed at, Google Scholar, Cross Ref

Get the App